Efeitos da terapia combinada atorvastatina e clopidogrel na biodisponibilidade da estatina e na função plaquetária em pacientes com doença coronária estável

Pinheiro, Luiz Fernando Muniz; Izar, Maria Cristina de Oliveira; Kasmas, Soraia Kani; França, Carolina Nunes; Fischer, Simone Cristina Matheus; Barbosa, Simone Pinto de Melo; De Nucci, Gilberto; Ilha, Jaime; Chen, Lu Chi; Carvalho, Antonio Carlos; Póvoa, Rui Manoel dos Santos; Bianco, Henrique Tria; Fonseca, Francisco Antonio Helfenstein.
Rev. bras. cardiol. invasiva ; 18(2): 185-192, jun. 2010.
Artículo en Portugués | LILACS | ID: lil-559925

Documentos relacionados

  1. Statin Use Improves Cardiometabolic Protection Promoted By Physical Training in an Aquatic Environment: A Randomized Clinical Trial.
  2. Treat-to-Target or High-Intensity Statin in Patients With Coronary Artery Disease: A Randomized Clinical Trial.
  3. Evaluating the effect of atorvastatin exposure and vitamin D levels on lipid outcomes in people with HIV-1 with suppressed HIV-1 RNA and LDL cholesterol <130 mg/dL.
  4. [Efficacy and safety of various doses of hybutimibe monotherapy or in combination with atorvastatin for primary hypercholesterolemia: a multicenter, randomized, double-blind, double-dummy, parallel-controlled phase Ⅲ clinical trial].
  5. Optimizing Post-Acute Coronary Syndrome Dyslipidemia Management: Insights from the North American Acute Coronary Syndrome Reflective III.
  6. Why not to interfere with LDL-cholesterol freefall and why not to talk badly about statins.
  7. Efficacy of combination therapy with ezetimibe and statins versus a double dose of statin monotherapy in participants with hypercholesterolemia: a meta-analysis of literature.
  8. Effect of Statin Therapy on Cardiovascular Outcome in Stroke Patients with Low Baseline Low-Density Lipoprotein Cholesterol.
  9. COMBINATION THERAPY EFFECTIVENESS OF EZETIMIBE AND ATORVASTATIN IN PATIENTS WITH ACUTE CORONARY SYNDROME.
  10. High-Sensitivity C-Reactive Protein Combined with Low-Density Lipoprotein Cholesterol as the Targets of Statin Therapy in Patients with Acute Coronary Syndrome.